ArticleScientific reports2018

Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.

Guangrui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.